Dr. Yousef Zakharia

Medical Oncologist

Mayo Clinic AZ

Published Articles (1)

A New Combination in Kidney Cancer Therapy: High Doses of Seleno-L-Methionine and Axitinib in a Phase I Trial

March 19, 2025

A Phase I trial explores the safety, efficacy, and tumor-suppressing effects of high-dose Seleno-L-Methionine (SLM) with Axitinib in metastatic clear cell renal carcinoma (mccRCC), showing promising early results.